Cuprina Holdings (cayman) Limited · NASDAQ:CUPR

Cuprina Holdings (cayman) — Investor Presentation (May 2026)

20 slides from Cuprina Holdings (cayman)'s investor presentation, May 19, 2026

  1. Slide 1: From Chronic to Closure

    Company Presentation FROM CHRONIC TO CLOSURE Cuprina Holdings (Cayman) Limited | NASDAQ: CUPR 1

  2. Slide 2: Disclaimer

    Disclaimer All statements in this presentation, other than those relating to historical facts, are “forward-looking statements.” These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, and strategies; statements that contain projections of

  3. Slide 3: About Cuprina

    3 About Cuprina CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Cuprina is a Singapore biomedical and biotechnology company developing and commercializing treatments for management of chronic wounds as well as cosmeceuticals for the health and beauty sector. We market our chronic wound care product

  4. Slide 4: Our Products: Commercialized / Pipeline

    4 Our Products CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Commercialized / Pipeline 2020 2023 2026 Q4 2027 + Maggot Mend Skin IVF Media Anuran Debridement Restoration Product Bullfrog Collagen In-Vitro Sponge Dressing Therapy* Balm Fertilization Solution Chronic Wound Cosmeceutical Anuran Trea

  5. Slide 5: Maggot Debridement Therapy (MDT)

    5 Maggot Debridement CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Therapy (MDT) • Live, sterile maggots achieve non- surgical removal of damaged, dead or infected tissue from chronic wounds. • Doesn’t harm healthy tissue; proven safe with minimal side effects. • Reduces chronic wound infections,

  6. Slide 6: Clinical Studies: Efficacy & Safety of MDT

    6 Clinical Studies CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Efficacy & Safety of MDT Yeo et al. (2022) Wilasrusmee et al. (2014) MDT had limb salvage Healing with MDT was 19 rate of 90.9%. weeks shorter than with conventional treatment. MDT is safe method of debridement. Ulcers treated with

  7. Slide 7: Cosmeceuticals

    7 Cosmeceuticals MEND SKIN RESTORATION BALM CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR (Commercialized in 2023) • Hydration balm formulated for sports enthusiasts • Contains Collagen, Hydroxyethyl Urea, Natural Plant Extracts • Available via retailers, gyms, online platforms in Singapore, Mala

  8. Slide 8: Pipeline: Wound Care Products

    PIPELINE WO UN D CAR E PRO DUCTS

  9. Slide 9: Anuran Medical Wound Care Dressings

    9 PIPELINE WOUND CARE PRODUCTS CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Anuran Medical Wound Care Dressings Made with collagen derived from American bullfrog skin with superior wound closure results NATURAL 90% CGMP- HEALING WOUND CLOSURE COMPLIANT Direct contact of dressing with Tests show

  10. Slide 10: Anuran Dressings: Regulatory and Expansion Path

    10 PIPELINE WOUND CARE PRODUCTS CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Anuran Medical Wound Care Dressings Currently undergoing ISO 10993 biocompatibility testing. Intend to commence clinical trials in Singapore by end of 2026. Step One Step Two United Singapore Further States Expansion Ma

  11. Slide 11: Anuran Hydrogel & Particles

    11 PIPELINE WOUND CARE PRODUCTS 1 ANURAN HYDROGEL CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Anuran A gel application of our collagen wound treatment Hydrogel & Particles 2 Wound Treatments ANURAN PARTICLES • Treatment aimed at wound cavities • Under development via research collaboration agre

  12. Slide 12: Hirudotherapy: Medical Leech Therapy

    12 PIPELINE WOUND CARE PRODUCTS CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Hirudotherapy Medical Leech Therapy Development est. to be completed 2026=2027 Clinical Study Literature Has Shown: Promotes Exclusive • Effectiveness of hirudotherapy in wounds Healing Rights that did not respond to co

  13. Slide 13: Market Opportunities for Chronic Wound Treatments

    13 Market Opportunities CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR For Chronic Wound Treatments Global Chronic Wound Main Drivers Market Size [2] • Aging Populations 18M $30 • Prevalence of Lifestyle 7.4% Diseases (Diabetes) $25.22B $25 • Increasing Costs of Healthcare CAGR • Persistence of $2

  14. Slide 14: Projected Market Growth for Chronic Wound Treatments

    14 Projected Market Growth CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR For Chronic Wound Treatments Southeast Gulf CoOp China Asia Council (GCC) Diabetes Cases Wound Care Undiagnosed Wound Care Wound Care Diabetes in Mainland Market Growth Diabetes Cases Market Growth Market Growth Cases [5] Ch

  15. Slide 15: In-Vitro Fertilization (IVF) Media

    15 In-Vitro Fertilization (IVF) Media CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Other Pipeline Products • We have constructed an IVF media production facility and obtained Total Assisted ISO13485 certification and dealer Reproductive Technology license. market expected to grow from • IVF medi

  16. Slide 16: Medical Waste Recycling

    16 Medical Waste Recycling CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Other Pipeline Products • We have secured exclusive Southeast Asia licensing rights to UNIDO/GEF-demonstrated medical waste recycling technology, in collaboration with our partner Zhejiang Heliang Technology Co., Ltd. • Tech

  17. Slide 17: Competitive Strengths

    17 Competitive Revenue Rich Product Pipeline CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Strengths New wound care products, IVF media solutions likely add significant revenue next year and beyond Innovative Innovative Tech Product Portfolio in Pipeline Products Wound care products use bioactive

  18. Slide 18: Management Team and Board of Directors

    18 Management Team CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR World-Class Leadership Board of Directors Mr. Teo Peng Mr. Jimmy Lee Mr. Koh Pee Kwang Peng Siew Keat Executive director of Director at Wenul HL Pte. 17+ years banking Centurion Corporation Ltd., a real estate experience at DBS Bank

  19. Slide 19: Medical & Scientific Advisory Board

    19 Medical & Scientific Advisory Board CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR Dr. Ronald A. Dr. Yong Sherman Enming Heads Clinical Leadership on Bio-Therapeutics, Training, Education and Dr. Yong is a is a highly respected Consultant in the Department of Endocrinology Awareness initiatives

  20. Slide 20: CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR

    CUPRINA HOLDINGS (CAYMAN) LIMITED | NASDAQ: CUPR

Cuprina Holdings (Cayman) — Investor Presentation (May 2026) on 6ix